Systems for Improved Access to Pharmaceuticals and Services Program

Systems for Improved Access to Pharmaceuticals and Services Program

Overview

Medicines are indispensable for improving health and saving the lives of people who need them. To be fully effective and safe, they must also be correctly prescribed and appropriately used.

From 2011 to 2018, the USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program ensured equitable, affordable access to safe, quality-assured medicines and related services in 46 countries throughout Africa, Asia, Europe, Latin America and the Caribbean, the Middle East, and Oceania.

The SIAPS pharmaceutical systems strengthening approach included local counterparts and partners in addressing five interrelated health system functions—governance, human resources, information, financing, and service delivery—with a focus on medicines.

Our programmatic work tackled systemic deficiencies, going beyond the selection, procurement, and distribution of pharmaceutical products to include dispensing and supplying pharmaceuticals to individuals and providing medication-related information and counseling. Treatment focused on critical health areas such as family planning, HIV and AIDS, malaria, maternal and child health, TB, neglected tropical diseases, and Ebola.

By helping countries meet disease-specific targets, we supported effective, resilient pharmaceutical systems in providing a wider range of medicines and products, contributing to improved health outcomes.

The USAID-funded Systems for Improved Access to Pharmaceuticals and Services (SIAPS) Program worked in Bangladesh to address barriers to essential health commodities. The objective was to strengthen the ability of policy makers, health care providers, and institutions to improve commodity management and ensure the continuous availability of commodities.
Although a variety of tools are available to measure different elements of pharmaceutical systems, few attempts have been made to conceptualize a “pharmaceutical system” as an entity and there is no clearly defined approach for tracking progress in strengthening this critical health subsystem. The webinar’s objectives were to present definitions of a pharmaceutical system and pharmaceutical system strengthening and describe the work undertaken by SIAPS to develop these definitions and identify metrics for tracking progress in strengthening pharmaceutical systems, with a focus on low- and middle-income countries.

Donors & Partners

Donors

United States Agency for International Development (USAID)

Partners

Accreditation Council for Pharmacy Education (ACPE)Harvard University

Logistics Management Institute (LMI)

University of Washington

African Medical and Research Foundation

Ecumenical Pharmaceutical Network

Results for Development (R4D)

Imperial Health Sciences

VillageReachWilliam Davidson Institute at the University of Michigan